Wound News and Research

RSS

First meeting of WHO H1N1 response probe concludes

The first meeting of external experts tasked with reviewing the WHO's handling of the H1N1 (swine flu) virus came to a close Wednesday, with health leaders maintaining it was still too early to declare the pandemic over, Agence France-Presse reports.

16 Apr 2010

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.

15 Apr 2010

ETC's BioMedical Division to introduce new BARA-MED Select monoplace hyperbaric chamber

Environmental Tectonics Corporation today announced that its BioMedical Division will be exhibiting their new BARA-MED Select monoplace hyperbaric chamber. This new chamber, which is an addition to ETC's monoplace line, includes an undercarriage gurney storage for optimized space usage and features a fourth-generation, automated computerized operating system for control and recordkeeping, a passive pressure relief mattress, SMOOTH-RIDE™, and an adjustable height gurney and computerized treatment protocols.

15 Apr 2010

Use of silver dressing in burn cases questioned

The use of expensive silver dressing in burn cases is being brought under the scanner by an editorial in the Drug and Therapeutics Bulletin. The NHS has increased its spending from £23 million in 2005 to around £25 million in 2006/7 on such products. The author asks if expensive silver dressing is really justified when cheaper alternatives are available.

15 Apr 2010

XOMA expands anti-inflammatory antibody intellectual property portfolio

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).

13 Apr 2010

NeoStem opens new adult stem cell collection center in Austin, TX

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced the launch of the newest adult stem cell collection center in its network to open in Austin, TX on April 15, 2010.

13 Apr 2010

Cytomedix to acquire Sorin's Angel blood separation system and activAT Autologous Thrombin Processing Kit

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.

13 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

New methodology helps investigate unfolding of DNA

NYU Langone Medical Center researchers have developed a powerful new method to investigate the discrete steps necessary to turn on individual genes and examine how the process goes wrong in cancer and other diseases. The finding, based on seven years of research and described in the April 9 issue of Molecular Cell, allows scientists to investigate the unfolding of DNA, a process required for gene activation.

9 Apr 2010

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

HemCon Medical Technologies, Inc., an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd., a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon's line of revolutionary wound and oral care dressings throughout Japan.

9 Apr 2010

Role of beta defensins in development of chronic inflammatory response in the brain

Researchers at the Case Western Reserve University School of Dental Medicine and School of Medicine will look for evidence within the brain for human beta defensin peptide function-proteins important to the peripheral body's natural defense system against infection from the outside environment.

8 Apr 2010

ANA recognizes WOC nursing as specialty

Wound, Ostomy and Continence nursing is one of the newest specialties recognized by the American Nurses Association. The Wound, Ostomy & Continence Nurses Society was recently notified of the ANA's decision.

8 Apr 2010

GE Capital, Healthcare Financial Services supports CCS Medical with $35M revolving line of credit

GE Capital, Healthcare Financial Services today announced it has provided a $35 million revolving line of credit to CCS Medical, Inc. The loan will be used to refinance existing debt, provide working capital and support growth initiatives following CCS Medical's exit from Chapter 11 bankruptcy protection on March 31, 2010.

7 Apr 2010

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Sechrist Industries to design 1000th Model 3200 monoplace hyperbaric chamber

The one-thousandth Model 3200 monoplace hyperbaric chamber to be designed and manufactured by HBO leader, Sechrist Industries, will be delivered to the Medical Center of Plano in Plano, Texas. The milestone, achieved by no other hyperbaric technology company, attests to the increasing demand for hyperbaric oxygenation in a wide variety of indications.

6 Apr 2010

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.

6 Apr 2010

VITAS Innovative Hospice Care begins serving patients with life-limiting diagnoses in Columbus

VITAS, the nation's leading hospice provider, is now serving patients with life-limiting diagnoses and their families in the greater Columbus area, including those in Delaware, Fairfield, Franklin, Licking, Madison, Pickaway and Union counties. VITAS also provides quality, compassionate end-of-life care in Ohio to patients and families in Cleveland, Cincinnati and Dayton.

3 Apr 2010

Patient-safety incidents: 10% died

Nearly one million patient-safety incidents occurred among Medicare patients over the years 2006, 2007, 2008, a figure virtually unchanged since last year's annual study of patient safety by HealthGrades, the leading independent healthcare ratings organization. In all, the incidents were associated with $8.9 billion in costs. One in ten patients -- 99,180 individuals -- experiencing a patient-safety incident died as a result, the study found.

1 Apr 2010

Derma Sciences reports 69% increase in Advanced Wound Care sales for fourth-quarter 2009

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months and fiscal year ended December 31, 2009.

1 Apr 2010

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, reports its financial results for the fourth quarter and full year ended December 31, 2009, and on its progress for the year.

31 Mar 2010

Wound News and Research

First meeting of WHO H1N1 response probe concludes

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

ETC's BioMedical Division to introduce new BARA-MED Select monoplace hyperbaric chamber

Use of silver dressing in burn cases questioned

XOMA expands anti-inflammatory antibody intellectual property portfolio

NeoStem opens new adult stem cell collection center in Austin, TX

Cytomedix to acquire Sorin's Angel blood separation system and activAT Autologous Thrombin Processing Kit

Tβ4 therapy for ocular disorders closer to reality

New methodology helps investigate unfolding of DNA

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

Role of beta defensins in development of chronic inflammatory response in the brain

ANA recognizes WOC nursing as specialty

GE Capital, Healthcare Financial Services supports CCS Medical with $35M revolving line of credit

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

Sechrist Industries to design 1000th Model 3200 monoplace hyperbaric chamber

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

VITAS Innovative Hospice Care begins serving patients with life-limiting diagnoses in Columbus

Patient-safety incidents: 10% died

Derma Sciences reports 69% increase in Advanced Wound Care sales for fourth-quarter 2009

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News